Treatment of Oral Leukoplakia with Diode Laser: a Pilot Study on Indian Subjects

• Published in: Asian Pacific journal of cancer prevention : APJCP 2015, Vol.16 (18), p.8383-8386
• Main Authors: Kharadi, Usama A Rashid, Onkar, Sanjeev, Birangane, Rajendra, Chaudhari, Swapnali, Kulkarni, Abhay, Chaudhari, Rohan
• Format: Article
• Language: Korean
• ISSN: 1513-7368; 2476-762X

Background: To evaluate the safety, convenience and effectiveness of 940nm diode laser for treatment of homogenous leukoplakia. Materials and Methods: Ten patients having homogenous leukoplakia which were diagnosed clinically were selected from an Indian dental educational institution for the study. Toludine blue staining was applied locally over the lesion. The area where there was increased uptake of stain was excised using a 940 nm EZLASE TM diode laser (BIOLASE-USA). Results: Although various treatment modalities have been tried and the search continues for novel treatment modalities for complete removal of homogenous leukoplakia, from results of our preliminary pilot study it is clear that the use of 940 nm diode laser as a treatment modality for homogenous leukoplakia is a good substitute. Healing was perfect without any complication within a duration of 1 month. Pain intensity was also mild and absolutely zero on the VAS scale after 1 month follow up. Conclusions: 940 nm diode lasers are safe and can be effectively used as a treatment modality of homogenous leukoplakia, without any complication and without compromising health and oral function of patients. Considering recurrence factor, long term follow up for patients is a must.